Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LeMaitre VascularLMAT +0.78%100 Cash Ratio is 12.57 as of Jun. 2026, which is 290% above its 10-year median of 3.22. GuruFocus rates LMAT with a GF Score™ of 100/100 and a GF Value™ of $95.26 (Modestly Undervalued). Among 840 Medical Devices & Instruments companies, LeMaitre Vascular ranks better than 97.62% on this metric.
LeMaitre Vascular has a Cash Ratio of 12.57. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.
The historical rank and industry rank for LeMaitre Vascular's Cash Ratio or its related term are showing as below:
LMAT'
s Cash Ratio Range Over the Past 10 Years
Min: 0.56 Med: 3.22 Max: 12.57
Current: 12.57
During the past 13 years, LeMaitre Vascular's highest Cash Ratio was 12.57. The lowest was 0.56. And the median was 3.22.
LMAT's Cash Ratio is ranked better than 97.62% of 840
companies
in the Medical Devices & Instruments industry
Industry Median: 0.97
vs LMAT: 12.57
LeMaitre Vascular (NAS:LMAT) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
LeMaitre Vascular Cash Ratio Related Terms
LeMaitre Vascular Cash Ratio Historical Data
* Premium members only.
The historical data trend for LeMaitre Vascular's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, LeMaitre Vascular's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LeMaitre Vascular Cash Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LeMaitre Vascular's Cash Ratio distribution charts can be found below:
* The bar in red indicates where LeMaitre Vascular's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LeMaitre Vascular (LMAT) has a Cash Ratio of 12.57 as of Jun. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on LeMaitre Vascular and its competitors. This is 290% above median its historical median of 3.22. Over the past decade, LeMaitre Vascular's Cash Ratio has ranged from 0.56 to 12.57. According to the industry distribution chart, LeMaitre Vascular ranks #20 out of 840 companies in the Medical Devices & Instruments industry, placing it in the top 2.4%.
Is LeMaitre Vascular's Cash Ratio too high?
LeMaitre Vascular's current Cash Ratio of 12.57 is 290% above median its 10-year median of 3.22. Over the past 10 years, this metric has ranged from a low of 0.56 to a high of 12.57. The Medical Devices & Instruments industry median Cash Ratio is 0.97. LeMaitre Vascular's value of 12.57 is 1195.9% above this industry median. Based on the distribution chart, LeMaitre Vascular ranks #20 out of 840 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, LeMaitre Vascular has a GF Score™ of 100/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does LeMaitre Vascular's Cash Ratio compare to PLSE and XRAY?
According to the Medical Devices & Instruments industry distribution chart, LeMaitre Vascular ranks #20 out of 840 companies for Cash Ratio. This places LeMaitre Vascular in the top 2% of its industry — outperforming the majority of peers. The industry median Cash Ratio is 0.97. LeMaitre Vascular's value of 12.57 is 1195.9% above this benchmark. Historically, LeMaitre Vascular's own Cash Ratio has ranged from 0.56 to 12.57 over the past decade. While the company's 10-year median is 3.22 vs. the industry median of 0.97, LeMaitre Vascular has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Medical Devices & Instruments company?
The median Cash Ratio among Medical Devices & Instruments companies is 0.97, based on 840 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LeMaitre Vascular's current Cash Ratio of 12.57 is 1195.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on LeMaitre Vascular and its competitors. For the Medical Devices & Instruments industry, the median Cash Ratio is 0.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LeMaitre Vascular's current Cash Ratio is 12.57, which is 290% above median its own 10-year median of 3.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LeMaitre Vascular stock overvalued right now?
Based on GuruFocus' analysis, LeMaitre Vascular (LMAT) is currently considered Modestly Undervalued. The stock's GF Value™ is $95.26, compared to a current price of $81.45 — trading 14.5% below its estimated fair value. The current Cash Ratio is 12.57, which is 290% above median its 10-year median of 3.22 and 1195.9% above the Medical Devices & Instruments industry median of 0.97. LeMaitre Vascular's overall GF Score™ is 100/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For LeMaitre Vascular (LMAT), the current Cash Ratio is 12.57 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LeMaitre Vascular (LMAT) Overvalued in 2026?
Based on GuruFocus' analysis, LeMaitre Vascular stock appears to be undervalued.
The current stock price of $81.45 is trading 14.5% below its estimated GF Value™ of $95.26.
GuruFocus considers LeMaitre Vascular to be Modestly Undervalued.
Key valuation signals for LMAT:
Cash Ratio: 12.57 (290% above median its 10-year median of 3.22)
GF Value™: $95.26 vs. price of $81.45 (14.5% below fair value)
Industry Position: 1195.9% above the Medical Devices & Instruments median (#20 of 840)
No single metric tells the full story. See the LMAT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
100GF Score
Get the complete analysis for LMAT
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LMAT has been successfully added to your 
